To study the ability of Olanzapine to control Cisplatin-induced emesis
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/11/038303
- Lead Sponsor
- Dr P Rama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Patients receiving Cisplatin will be recruited.
Exclusion Criteria
1. Patients who deviate from the already designed protocol
2. Pregnant and lactating women
3. Psychiatric patients
4. Patients with arrythmia
5. Patients with renal impairment (Creatinine clearance: <15ml/min/1.73m 2 )
6. Patients treated with Amitriptyline
7. Patients experiencing nausea/ vomiting due to mechanical obstruction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method